OneMedNet Corporation (ONMD)
NASDAQ: ONMD · Real-Time Price · USD
1.427
+0.077 (5.79%)
Dec 26, 2024, 2:50 PM EST - Market open
OneMedNet Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Revenue | 0.96 | 1.02 | 1.15 | 1.09 | 0.82 |
Revenue Growth (YoY) | 1.36% | -11.37% | 5.58% | 32.49% | - |
Cost of Revenue | 1.21 | 1.15 | 1.51 | 1.21 | 0.61 |
Gross Profit | -0.25 | -0.13 | -0.36 | -0.11 | 0.21 |
Selling, General & Admin | 8.88 | 6.61 | 10.11 | 1.95 | 2.84 |
Research & Development | 1.19 | 1.63 | 0.95 | 0.64 | 0.31 |
Operating Expenses | 10.08 | 8.25 | 11.06 | 2.6 | 3.14 |
Operating Income | -10.33 | -8.37 | -11.43 | -2.71 | -2.93 |
Interest Expense | -0.87 | -0.75 | -0.4 | -0.2 | - |
Interest & Investment Income | - | - | - | - | 0.19 |
Other Non Operating Income (Expenses) | 22.01 | -3.58 | 4.44 | -0.03 | -0.32 |
EBT Excluding Unusual Items | 10.81 | -12.7 | -7.39 | -2.94 | -3.06 |
Gain (Loss) on Sale of Investments | - | - | 1.37 | - | - |
Asset Writedown | -10.5 | -10.5 | - | - | - |
Other Unusual Items | 0.02 | - | - | - | 0.23 |
Pretax Income | 0.32 | -23.21 | -6.01 | -2.94 | -2.82 |
Income Tax Expense | - | - | 0.21 | - | - |
Net Income | 0.32 | -23.21 | -6.23 | -2.94 | -2.82 |
Net Income to Common | 0.32 | -23.21 | -6.23 | -2.94 | -2.82 |
Shares Outstanding (Basic) | 39 | 24 | 5 | 4 | - |
Shares Outstanding (Diluted) | 39 | 24 | 5 | 4 | - |
Shares Change (YoY) | 21.67% | 416.94% | 5.44% | - | - |
EPS (Basic) | 0.01 | -0.98 | -1.37 | -0.68 | - |
EPS (Diluted) | 0.01 | -0.98 | -1.37 | -0.68 | - |
Free Cash Flow | 6.3 | 8.18 | 87.18 | -1.87 | -2.13 |
Free Cash Flow Per Share | 0.16 | 0.35 | 19.12 | -0.43 | - |
Gross Margin | -26.30% | -12.52% | -31.29% | -10.39% | 25.77% |
Operating Margin | -1078.50% | -819.68% | -991.16% | -248.27% | -355.83% |
Profit Margin | 33.79% | -2271.37% | -540.42% | -269.37% | -342.41% |
Free Cash Flow Margin | 657.77% | 800.39% | 7562.99% | -171.68% | -257.88% |
EBITDA | -10.29 | -8.35 | -11.4 | -2.7 | -2.92 |
EBITDA Margin | - | - | - | -246.95% | - |
D&A For EBITDA | 0.04 | 0.03 | 0.02 | 0.01 | 0.01 |
EBIT | -10.33 | -8.37 | -11.43 | -2.71 | -2.93 |
EBIT Margin | - | - | - | -248.27% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.